Skye Bioscience (SKYE)
Developing an investigational peripheral cannabinoid-receptor antibody for obesity.
$1.89
Pre-market+0.04 (+2.16%)
At close$1.85(+2.78%)
Something off on this page? Send us feedback.
Next report
Nov 9, 2026
in 67 days
EPS estimate
−$1.14
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.24−$0.28−$0.44−$0.32−$0.36−$0.32−$2.16Pending
Estimate−$0.28−$0.31−$0.34−$0.33−$0.30−$0.29−$2.04−$1.14
Surprise+14.3%+9.7%−29.4%+3.0%−21.2%−10.3%−5.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.14 | — | — |
| Aug 2026 | −$2.04 | −$2.16 | −5.9% |
| May 2026 | −$0.29 | −$0.32 | −10.3% |
| Mar 2026 | −$0.30 | −$0.36 | −21.2% |
| Nov 2025 | −$0.33 | −$0.32 | +3.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$1.14 | — | — | — | — | — | — |
| Aug 14, 2026 | −$2.04 | −$2.16 | −5.9% | — | — | — | −7.4% |
| May 12, 2026 | −$0.29 | −$0.32 | −10.3% | — | — | — | +0.8% |
| Mar 10, 2026 | −$0.30 | −$0.36 | −21.2% | — | — | — | −9.7% |
| Nov 10, 2025 | −$0.33 | −$0.32 | +3.0% | — | — | — | +2.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 22, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 6, 2022 | |||||||
| Mar 25, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 7, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 21, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 14, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 19, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Aug 12, 2017 | |||||||
| May 12, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 12, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 21, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 14, 2015 | |||||||